First 2,500 patients enrolled!
The PREPARE study team is proud to announce that the first 2,500 patients have been enrolled for the PREPARE study! Continue reading
News
4th U-PGx Personalized Medicine Day
The 4th U-PGx Personalized Medicine Day will be organized in Stockholm, Sweden at 18th of June 2018. Continue reading
U-PGx Summer School “Towards Pharmacogenomics in Clinic”
The U-PGx Summer School will be organized August 20th to 23th in Bonn, Germany. Continue reading
The 3rd U-PGx Personalized Medicine Day, ”Pharmacogenomics in Oncology: Deciphering the Ethical, Legal and Societal Issues”
The 3rd U-PGx Personalized Medicine Day in Toulouse was successfully organized and completed on 17th November 2017 with the theme ”Pharmacogenomics in Oncology: Deciphering the Ethical, Legal and Societal Issues”. Continue reading
First 1,000 patients enrolled!
The PREPARE study team is proud to announce that the first 1,000 patients have been enrolled for the PREPARE study! Continue reading
Population modeling in patients with sunitinib-treated cancer
The tyrosine kinase inhibitor sunitinib is used as first-line therapy in patients with metastasized renal cell carcinoma (mRCC), given in fixed-dose regimens despite its high variability in pharmacokinetics (PKs). Interindividual variability of drug exposure may be responsible for differences in response. Therefore, dosing strategies based on pharmacokinetic/pharmacodynamic (PK/PD) models may be useful to optimize treatment. Continue reading
3rd UPGx Personalized Medicine Day
The 3rd UPGx Personalized Medicine Day will be organized in Toulouse, France. The meeting will be co-organized by the Golden Helix Foundation and the University of Toulouse, both partners of the Ubiquitous Pharmacogenomics (UPGx) project, funded by the European Commission (H2020-668353). Continue reading
H.E. the United States Ambassador in Greece visits UPAT and gets informed about the U-PGx project
On July 21st, 2017, H.E. the United States Ambassador to Greece Mr. Geoffrey Pyatt visited the Laboratory of Molecular Biology and Immunology, University of Patras (UPAT), as part of his visit to academic entities in Patras that produce and offer innovative results and services in the biotechnology and healthcare sectors.
The PREPARE Study is open for recruitment!
The PREPARE (PREemptive Pharmacogenomic testing for prevention of Adverse drug Reactions) Study has been opened for recruitment! The first patient has been included in Aviano, Italy. Continue reading
2nd UPGx Personalized Medicine Day
The 2nd UPGx Personalized Medicine Day will be organized in Vienna, Austria on Friday May 12th, 2017. The meeting will be organized at the Medical University of Vienna and will follow the 2nd Consortium Meeting of the UPGx project that will be held May 10-11, 2017. Continue reading